Emcure Pharmaceuticals Limited — Norfloxacin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Norfloxacin · $374.4K export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #6 Indian exporter of Norfloxacin with $374.4K in export value and 35 verified shipments. Emcure Pharmaceuticals Limited holds a 4.5% market share in Norfloxacin exports across 3 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Norfloxacin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Norfloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CONGO | $199.4K | 6 | 34.7% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $136.8K | 13 | 23.8% |
| CONGO D REPULIC | $116.0K | 7 | 20.2% |
| FRANCE | $106.3K | 10 | 18.5% |
| MALAWI | $15.2K | 5 | 2.7% |
Emcure Pharmaceuticals Limited exports Norfloxacin to 5 countries. The largest destination is CONGO accounting for 34.7% of Emcure Pharmaceuticals Limited's Norfloxacin shipments, followed by CONGO, THE DEMOCRATIC REPUBLIC OF THE (23.8%) and CONGO D REPULIC (20.2%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Norfloxacin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GALAXY PHARMACEUTIQUE CORP | CONGO | $199.4K | 6 |
| GALAXY PHARMACEUTIQUE CORP. | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $167.2K | 12 |
| E.P.DIS(EURAPHARMA) | FRANCE | $67.9K | 6 |
| HJ PHARMA SARL | CONGO D REPULIC | $43.4K | 4 |
| MODEX CONGO SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $42.2K | 4 |
| EPDIS EURAPHARMA ZAC DU GRAND | FRANCE | $21.8K | 3 |
| E.P.DIS | FRANCE | $16.6K | 1 |
| PHARMAVET LIMITED | MALAWI | $15.2K | 5 |
Emcure Pharmaceuticals Limited supplies Norfloxacin to 8 buyers globally. The largest buyer is GALAXY PHARMACEUTIQUE CORP (CONGO), followed by GALAXY PHARMACEUTIQUE CORP. (CONGO, THE DEMOCRATIC REPUBLIC OF THE) and E.P.DIS(EURAPHARMA) (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Norfloxacin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $4.9M worth of Norfloxacin through 1,394 shipments from 207 suppliers to 96 countries, serving 460 buyers globally. Emcure Pharmaceuticals Limited contributes $374.4K to this total, accounting for 4.5% of India's Norfloxacin exports. Emcure Pharmaceuticals Limited ships Norfloxacin to 5 countries through 8 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Norfloxacin Exports?
Emcure Pharmaceuticals Limited's average Norfloxacin shipment value is $10.7K per consignment, based on 35 shipments totaling $374.4K. The largest destination is CONGO (34.7% of Emcure Pharmaceuticals Limited's Norfloxacin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Norfloxacin Exporters?
Emcure Pharmaceuticals Limited ranks #6 among 207 Indian Norfloxacin exporters with a 4.5% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.2M), IPCA LABORATORIES LIMITED ($535.6K), PINNACLE LIFE SCIENCE PRIVATE LIMITED ($400.0K). Emcure Pharmaceuticals Limited processed 35 shipments to 3 destination countries.
What Norfloxacin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM NORMET 400/400MG TABLET 1X10 METRONIDAZOLE & NORFLOXACIN TABLETS 400MG/400MG | $100.0K | 2 |
| NORMET 200/200MG TABLETS-PACK SIZE-1X10TAB- (EACH FILM COATED TABLETS CONTAINS-NORFLOXACIN- 200MG AND METRONIDAZOLE-20 | $84.3K | 4 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM NORMET 100/100MG SUSPENSION 60 ML BT METRONIDAZOLE &NORFLOXACIN SUSPENSION 100/100 MG | $56.6K | 2 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM NORMET 200/200MG TABLET 1X10 METRONIDAZOLE & NORFLOXACIN TABLETS 200MG/200MG | $42.8K | 2 |
| NORMET 100/100 MG SUSPENSION 30 ML BT (METRONIDAZOLE & NORFLOXACIN SUSPENSION 100/100 MG) (PACK SIZE: 30 ML) | $42.2K | 3 |
| PHARMACEUTICAL PRODUCTS - NORMET 100/100MG SUSPENSION 30 ML BT ( METRONIDAZOLE& NORFLOXACIN SUSPENSION 100/100 MG ) | $26.5K | 1 |
| NORMET 100/100MG SUSPENSION 60ML BOTTLES (EACH 5ML CONTAINS NORFLOXACIN100MGAND METRONIDAZOLE -100MG SUSPENSION) | $25.7K | 3 |
| NORMET 100/100 MG SUSPENSION 60 ML BT (METRONIDAZOLE & NORFLOXACIN SUSPENSION 100/100 MG) Pack Size - 60 ML | $24.3K | 1 |
| PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM - FINISHED PRODUCT NORMET 200/200 MG TABLET 10X1X10 METRONIDAZOLE & NORFLOXACIN TABLETS 20 | $21.8K | 3 |
| NORMET 400/400MG TABLETS-PACK SIZE- 1X10TAB- (EACH FILM COATED TABLETS CONTAINS NORFLOXACIN400MG AND METRONIDAZOLE 4 | $20.1K | 3 |
Emcure Pharmaceuticals Limited exports 26 distinct Norfloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS ARTICLE / ODS / PRODUCT / ITEM NORMET 400/4 with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Norfloxacin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | PINNACLE LIFE SCIENCE PRIVATE LIMITED | $400.0K | 8 | 3 | $50.0K |
| 5 | ARBRO PHARMACEUTICALS PRIVATE LIMITED | $377.7K | 41 | 3 | $9.2K |
| 6 | EMCURE PHARMACEUTICALS LIMITED ★ | $374.4K | 35 | 3 | $10.7K |
| 4 | MEDICAMEN BIOTECH LIMITED | $300.0K | 6 | 3 | $50.0K |
| 7 | LINCOLN PHARMACEUTICALS LTD | $281.3K | 9 | 2 | $31.3K |
Emcure Pharmaceuticals Limited ranks #6 among 207 Indian Norfloxacin exporters. Average shipment value of $10.7K compared to the market average of $23.5K. The closest competitors by value are PINNACLE LIFE SCIENCE PRIVATE LIMITED and ARBRO PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Norfloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 186 | 13.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 140 | 10.0% |
| SAHAR AIR | 135 | 9.7% |
| DELHI AIR | 113 | 8.1% |
| NHAVA SHEVA SEA (INNSA1) | 109 | 7.8% |
| JNPT/ NHAVA SHEVA SEA | 67 | 4.8% |
| AHEMDABAD ICD | 41 | 2.9% |
| JNPT | 34 | 2.4% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Norfloxacin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Norfloxacin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Norfloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Norfloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching Emcure Pharmaceuticals Limited exporting Norfloxacin, covering 26 formulations to 5 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 460+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Norfloxacin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Norfloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Norfloxacin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Norfloxacin. For current shipment-level data, contact TransData Nexus.